i-Pen® Tear Osmolarity System registered in Japan
19 sept. 2017 14h45 HE
|
I-MED Pharma
MONTREAL, Sept. 19, 2017 (GLOBE NEWSWIRE) -- I-MED Pharma announced today the successful registration of its i-Pen® Tear Osmolarity System (“i-Pen®”) in Japan. The i-Pen® is an in-vivo handheld tear...
Investigational Cis-urocanic Acid Eye Drops for Dry Eye Syndrome Well Tolerated, in Phase 1 Clinical Study
28 juin 2012 10h03 HE
|
Laurantis Pharma OY
TURKU, FINLAND--(Marketwire - Jun 28, 2012) - Laurantis Pharma today announced that it has completed a phase 1 clinical study with its Cis-urocanic acid eye drops. The objective of the study was to...